The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression
Open Access
- 2 September 2002
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 196 (5), 693-704
- https://doi.org/10.1084/jem.20020845
Abstract
CD40 ligand (CD154) expression on activated T cells can be separated into an early TCR-dependent phase, which occurs between 0 and 24 h after activation, and a later extended phase, which occurs after 24 h and is reciprocally regulated by the cytokines IL-4 and IL-12. IL-4 represses, whereas IL-12 sustains CD154 expression. Consistent with this, Th1, but not Th2, cells express CD154 for extended periods. Differences in the duration of CD154 expression have important biological consequences because sustained, but not transient, expression of CD154 on activated T cells can prevent B cell terminal differentiation. Thus, the differential ability of Th cells to sustain CD154 expression is an important part of their helper function and should influence the activities of other CD40-expressing cell types.Keywords
This publication has 66 references indexed in Scilit:
- Signaling and Transcription in T Helper DevelopmentAnnual Review of Immunology, 2000
- CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania majorImmunity, 1996
- Protective Role of CD40 in Leishmania major Infection at Two Distinct Phases of Cell-Mediated ImmunityImmunity, 1996
- Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis InfectionImmunity, 1996
- Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responsesEuropean Journal of Immunology, 1995
- Generation and in vivo persistence of polarized Th1 and Th2 memory cellsImmunity, 1994
- CD40 ligand and its role in X-linked hyper-IgM syndromeImmunology Today, 1993
- Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokinesEuropean Journal of Immunology, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Human CD40‐ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE productionFEBS Letters, 1993